Norway· NO-ID_26E3D15B-FBDD-4B4E-AC3B-E79284EB84FF

Viscotears

A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carbomer, registered in Norway by Dr. Gerhard Mann Chem-pharm. Fabrik GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC S01XA20

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedViscotearsATCS01XA20REGISTER NO.NO-ID_26E3D15B-FBDD-4…PACKS LISTED5CHECKEDSeptember 25, 2026

Where it is registered

Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.

Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Carbomer
Manufacturer
Dr. Gerhard Mann Chem-pharm. Fabrik GmbH
Country
Norway (NO)
ATC code
S01XA20
ATC class
Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 5

  • no_merkevare_id
    ID_26E3D15B-FBDD-4B4E-AC3B-E79284EB84FF
  • no_varenummer
    529807
    120 x 0.6
  • no_varenummer
    541760
    30 x 0.6
  • gtin
    7046265298076
  • gtin
    7046265417606

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Künstliche tränenflüssigkeit und sonstige indifferente präparate in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All künstliche tränenflüssigkeit und sonstige indifferente präparate products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Carbomer Agepha
  • Belgium · Liposic
  • Germany · Carbomer Edo, Liposic
  • Denmark · Viscotears
  • Spain · Lipolasic
  • Finland · Viscotears
  • France · Aquarest, Lacrinorm
  • United Kingdom (Northern Ireland) · Viscotears, Viscotears Single Dose Unit
  • Greece · Liposic, Viscoter
  • Ireland · Geltears, Liposic
  • Iceland · Vidisic
  • Italy · Lipovisc
  • Luxembourg · Vidisic Edo, Vidisic®
  • Netherlands · Liposic, Vidisic Carbogel
  • Poland · Vidisic
  • Portugal · Liposic
  • Sweden · Viscotears
  • Slovakia · Vidisic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b788e1a1-3602-49da-8d7a-bf20f75ae961
GET /v1/drugs/b788e1a1-3602-49da-8d7a-bf20f75ae961?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Øyegel",
  "source": "fest",
  "status": "A",
  "atc_name": "Indifferente midler",
  "merkevare_id": "ID_26E3D15B-FBDD-4B4E-AC3B-E79284EB84FF",
  "name_form_strength": "Viscotears øyegel 2 mg/g",
  "prescription_group": "F"
}

See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.